Ghosh K, Prakash A, Dhara A, Hussain M, Shrivastav P, Kumar P, et al. Role of Supramolecule ErpY-Like Lipoprotein of Leptospira in Thrombin-Catalyzed Fibrin Clot Inhibition and Binding to Complement Factors H and I, and Its Diagnostic Potential. Infect Immun. 2019;87: pubmed publisher

Wittes J, Musch D. Should we test for genotype in deciding on age-related eye disease study supplementation?. Ophthalmology. 2015;122:3-5 pubmed publisher

Chew E, Klein M, Clemons T, Agrón E, Abecasis G. Genetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: to test or not to test?. Ophthalmology. 2015;122:212-5 pubmed publisher

Blaum B, Hannan J, Herbert A, Kavanagh D, Uhrin D, Stehle T. Structural basis for sialic acid-mediated self-recognition by complement factor H. Nat Chem Biol. 2015;11:77-82 pubmed publisher

Achila D, Liu A, Banerjee R, Li Y, Martinez Hackert E, Zhang J, et al. Structural determinants of host specificity of complement Factor H recruitment by Streptococcus pneumoniae. Biochem J. 2015;465:325-35 pubmed publisher

Shen L, FRAZER ABEL A, Reynolds P, Giclas P, Chappell A, Pangburn M, et al. Mechanistic understanding for the greater sensitivity of monkeys to antisense oligonucleotide-mediated complement activation compared with humans. J Pharmacol Exp Ther. 2014;351:709-17 pubmed publisher

Cai L, Zhu J, Yin D, Chen L, Jin P, Ma F. Identification and characterization of complement factor H in Branchiostoma belcheri. Gene. 2014;553:42-8 pubmed publisher

Loeven M, Rops A, Berden J, Daha M, Rabelink T, van der Vlag J. The role of heparan sulfate as determining pathogenic factor in complement factor H-associated diseases. Mol Immunol. 2015;63:203-8 pubmed publisher

Awh C, Hawken S, Zanke B. Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study. Ophthalmology. 2015;122:162-9 pubmed publisher

Saade C, Ganti B, Marmor M, Freund K, Smith R. Risk characteristics of the combined geographic atrophy and choroidal neovascularisation phenotype in age-related macular degeneration. Br J Ophthalmol. 2014;98:1729-32 pubmed publisher

Land M, Cooper R, Young J, Berg E, Kitchner T, Xiang Q, et al. Cone structure in subjects with known genetic relative risk for AMD. Optom Vis Sci. 2014;91:939-49 pubmed publisher

Myers C, Klein B, Gangnon R, Sivakumaran T, Iyengar S, Klein R. Cigarette smoking and the natural history of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology. 2014;121:1949-55 pubmed publisher

Matar D, Naqvi F, Racusen L, Carter Monroe N, Montgomery R, Alachkar N. Atypical hemolytic uremic syndrome recurrence after kidney transplantation. Transplantation. 2014;98:1205-12 pubmed publisher

Valoti E, Alberti M, Tortajada A, García Fernández J, Gastoldi S, Besso L, et al. A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation. J Am Soc Nephrol. 2015;26:209-19 pubmed publisher

Bernhard S, Fleury C, Su Y, Zipfel P, Koske I, Nordstrom T, et al. Outer membrane protein OlpA contributes to Moraxella catarrhalis serum resistance via interaction with factor H and the alternative pathway. J Infect Dis. 2014;210:1306-10 pubmed publisher

Huang L, Li Y, Guo S, Sun Y, Zhang C, Bai Y, et al. Different hereditary contribution of the CFH gene between polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese Han people. Invest Ophthalmol Vis Sci. 2014;55:2534-8 pubmed publisher

Ferluga J, Kishore U, Sim R. A potential anti-coagulant role of complement factor H. Mol Immunol. 2014;59:188-93 pubmed publisher

Wilkes M, Miller D, Mitchell M, Zanke B, Petersen M, Sisk R, et al. Investigation of choroidal neovascularization risk alleles in ocular histoplasmosis. Ophthalmology. 2014;121:1487-8.e1 pubmed publisher

Bonomo J, Palmer N, Hicks P, Lea J, Okusa M, Langefeld C, et al. Complement factor H gene associations with end-stage kidney disease in African Americans. Nephrol Dial Transplant. 2014;29:1409-14 pubmed publisher

Hautamäki A, Kivioja J, Seitsonen S, Savolainen E, Liinamaa M, Luoma A, et al. The IL-8, VEGF, and CFH polymorphisms and bevacizumab in age-related macular degeneration. Ophthalmology. 2014;121:973-973.e1 pubmed publisher

Boddu S, Lee M, Marsiglia M, Marmor M, Freund K, Smith R. Risk factors associated with reticular pseudodrusen versus large soft drusen. Am J Ophthalmol. 2014;157:985-993.e2 pubmed publisher

Grumach A, Ceccon M, Rutz R, Fertig A, Kirschfink M. Complement profile in neonates of different gestational ages. Scand J Immunol. 2014;79:276-81 pubmed publisher

Wang X, Geng P, Zhang Y, Zhang M. Association between complement factor H Val62Ile polymorphism and age-related macular degeneration susceptibility: a meta-analysis. Gene. 2014;538:306-12 pubmed publisher

Liu K, Chen L, Lai T, Tam P, Ho M, Chiang S, et al. Genes in the high-density lipoprotein metabolic pathway in age-related macular degeneration and polypoidal choroidal vasculopathy. Ophthalmology. 2014;121:911-6 pubmed publisher

Nozal P, Garrido S, Alba Domínguez M, Espinosa L, Peña A, Cordoba S, et al. An ELISA assay with two monoclonal antibodies allows the estimation of free factor H and identifies patients with acquired deficiency of this complement regulator. Mol Immunol. 2014;58:194-200 pubmed publisher

Faleri A, Santini L, Brier S, Pansegrau W, Lo Surdo P, Scarselli M, et al. Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties. FASEB J. 2014;28:1644-53 pubmed publisher

Rowan S, Weikel K, Chang M, Nagel B, Thinschmidt J, Carey A, et al. Cfh genotype interacts with dietary glycemic index to modulate age-related macular degeneration-like features in mice. Invest Ophthalmol Vis Sci. 2014;55:492-501 pubmed publisher

Del Tordello E, Vacca I, Ram S, Rappuoli R, Serruto D. Neisseria meningitidis NalP cleaves human complement C3, facilitating degradation of C3b and survival in human serum. Proc Natl Acad Sci U S A. 2014;111:427-32 pubmed publisher

Joachim N, Mitchell P, Rochtchina E, Tan A, Wang J. Incidence and progression of reticular drusen in age-related macular degeneration: findings from an older Australian cohort. Ophthalmology. 2014;121:917-25 pubmed publisher

Ardissino G, Tel F, Testa S, Marzano A, Lazzari R, Salardi S, et al. Skin involvement in atypical hemolytic uremic syndrome. Am J Kidney Dis. 2014;63:652-5 pubmed publisher

Schaumberg D, Rose L, DeAngelis M, Semba R, Hageman G, Chasman D. Prospective study of common variants in CX3CR1 and risk of macular degeneration: pooled analysis from 5 long-term studies. JAMA Ophthalmol. 2014;132:84-95 pubmed publisher

Ruseva M, Takahashi M, Fujita T, Pickering M. C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo. Clin Exp Immunol. 2014;176:84-92 pubmed publisher

Budzinskaia M, Pogoda T, Generozov E, Chikun E, Gurova I, Shchegoleva I, et al. [Contemporary pharmacogenetic approaches to the treatment of age-related macular degeneration]. Vestn Oftalmol. 2013;129:128-35 pubmed

McLaughlin M, Paglione M, Slakter J, Tolentino M, Ye L, Xu C, et al. Initial exploration of oral pazopanib in healthy participants and patients with age-related macular degeneration. JAMA Ophthalmol. 2013;131:1595-601 pubmed publisher

Cao S, Ko A, Partanen M, Pakzad Vaezi K, Merkur A, Albiani D, et al. Relationship between systemic cytokines and complement factor H Y402H polymorphism in patients with dry age-related macular degeneration. Am J Ophthalmol. 2013;156:1176-83 pubmed publisher

Lotery A, Gibson J, Cree A, Downes S, Harding S, Rogers C, et al. Pharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the IVAN Study. Ophthalmology. 2013;120:2637-2643 pubmed publisher

Fujimura Y. [Atypical hemolytic uremic syndrome]. Rinsho Ketsueki. 2013;54:1897-906 pubmed

Chen A, Seifert H. Structure-function studies of the Neisseria gonorrhoeae major outer membrane porin. Infect Immun. 2013;81:4383-91 pubmed publisher

Helgason H, Sulem P, Duvvari M, Luo H, Thorleifsson G, Stefansson H, et al. A rare nonsynonymous sequence variant in C3 is associated with high risk of age-related macular degeneration. Nat Genet. 2013;45:1371-4 pubmed publisher

Zhan X, Larson D, Wang C, Koboldt D, Sergeev Y, Fulton R, et al. Identification of a rare coding variant in complement 3 associated with age-related macular degeneration. Nat Genet. 2013;45:1375-9 pubmed publisher

Rayes J, Roumenina L, Dimitrov J, Repesse Y, Ing M, Christophe O, et al. The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status. Blood. 2014;123:121-5 pubmed publisher

Nolasco L, Nolasco J, Feng S, Afshar Kharghan V, Moake J. Human complement factor H is a reductase for large soluble von Willebrand factor multimers--brief report. Arterioscler Thromb Vasc Biol. 2013;33:2524-8 pubmed publisher

Neidich A, Neidich E, Lee A, Nicoletta J, Rohrer R, Milner L, et al. Novel use of intravenous immunoglobulin G in complement factor H missense mutation: a case report. Prog Transplant. 2013;23:213-6 pubmed publisher

Awh C, Lane A, Hawken S, Zanke B, Kim I. CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. Ophthalmology. 2013;120:2317-23 pubmed publisher

Yang M, Lai T, Tam P, Chiang S, Ng T, Rong S, et al. Association of CFH and SERPING1 polymorphisms with anterior uveitis. Br J Ophthalmol. 2013;97:1475-80 pubmed publisher

Agrahari G, Liang Z, Mayfield J, Balsara R, Ploplis V, Castellino F. Complement-mediated opsonization of invasive group A Streptococcus pyogenes strain AP53 is regulated by the bacterial two-component cluster of virulence responder/sensor (CovRS) system. J Biol Chem. 2013;288:27494-504 pubmed publisher

Kraivong R, Vasanawathana S, Limpitikul W, Malasit P, Tangthawornchaikul N, Botto M, et al. Complement alternative pathway genetic variation and Dengue infection in the Thai population. Clin Exp Immunol. 2013;174:326-34 pubmed publisher

Zhang Y, Nester C, Holanda D, Marsh H, Hammond R, Thomas L, et al. Soluble CR1 therapy improves complement regulation in C3 glomerulopathy. J Am Soc Nephrol. 2013;24:1820-9 pubmed publisher

Wilson V, Darlay R, Wong W, Wood K, McFarlane J, Schejbel L, et al. Genotype/phenotype correlations in complement factor H deficiency arising from uniparental isodisomy. Am J Kidney Dis. 2013;62:978-83 pubmed publisher

Sharma N, Sharma S, Gupta A, Prabhakar S, Singh R, Anand A. Predictive model for earlier diagnosis of suspected age-related macular degeneration patients. DNA Cell Biol. 2013;32:549-55 pubmed publisher

Skerka C, Chen Q, Fremeaux Bacchi V, Roumenina L. Complement factor H related proteins (CFHRs). Mol Immunol. 2013;56:170-80 pubmed publisher

Boiko E, Churashov S, Kamilova T. [Molecular genetic basis of age-related macular degeneration]. Vestn Oftalmol. 2013;129:86-90 pubmed

Dragon Durey M, Blanc C, Marinozzi M, van Schaarenburg R, Trouw L. Autoantibodies against complement components and functional consequences. Mol Immunol. 2013;56:213-21 pubmed publisher

Hörl S, Banki Z, Huber G, Ejaz A, Windisch D, Muellauer B, et al. Reduction of complement factor H binding to CLL cells improves the induction of rituximab-mediated complement-dependent cytotoxicity. Leukemia. 2013;27:2200-8 pubmed publisher

Faber C, Singh A, Krüger Falk M, Juel H, Sørensen T, Nissen M. Age-related macular degeneration is associated with increased proportion of CD56(+) T cells in peripheral blood. Ophthalmology. 2013;120:2310-6 pubmed publisher

Ambati J, Atkinson J, Gelfand B. Immunology of age-related macular degeneration. Nat Rev Immunol. 2013;13:438-51 pubmed publisher

Makou E, Herbert A, Barlow P. Functional anatomy of complement factor H. Biochemistry. 2013;52:3949-62 pubmed publisher

Uslu Gokceoglu A, Dogan C, Comak E, Koyun M, Akman S. Atypical hemolytic uremic syndrome due to factor H autoantibody. Turk J Pediatr. 2013;55:86-9 pubmed

Nan R, Tetchner S, Rodriguez E, Pao P, Gor J, Lengyel I, et al. Zinc-induced self-association of complement C3b and Factor H: implications for inflammation and age-related macular degeneration. J Biol Chem. 2013;288:19197-210 pubmed publisher

Chapin J, Eyler S, Smith R, Tsai H, Laurence J. Complement factor H mutations are present in ADAMTS13-deficient, ticlopidine-associated thrombotic microangiopathies. Blood. 2013;121:4012-3 pubmed publisher

Bhattacharjee A, Oeemig J, Kolodziejczyk R, Meri T, Kajander T, Lehtinen M, et al. Structural basis for complement evasion by Lyme disease pathogen Borrelia burgdorferi. J Biol Chem. 2013;288:18685-95 pubmed publisher

Massart A, Golmarvi S, Hachimi Idrissi S, Broeders E, Tournay Y, Nortier J, et al. Complement factor H functional assay may help to monitor atypical haemolytic uraemic syndrome: a pilot study. Acta Clin Belg. 2013;68:9-14 pubmed

Vaillancourt K, Bonifait L, Grignon L, Frenette M, Gottschalk M, Grenier D. Identification and characterization of a new cell surface protein possessing factor H-binding activity in the swine pathogen and zoonotic agent Streptococcus suis. J Med Microbiol. 2013;62:1073-1080 pubmed publisher

Schmidt C, Bai H, Lin Z, Risitano A, Barlow P, Ricklin D, et al. Rational engineering of a minimized immune inhibitor with unique triple-targeting properties. J Immunol. 2013;190:5712-21 pubmed publisher

Wolf Schnurrbusch U, Hess R, Jordi F, Stuck A, Sarra G, Wolf S, et al. Detection of Chlamydia and complement factors in neovascular membranes of patients with age-related macular degeneration. Ocul Immunol Inflamm. 2013;21:36-43 pubmed publisher

Thompson I, Liu B, Sen H, Jiao X, Katamay R, Li Z, et al. Association of complement factor H tyrosine 402 histidine genotype with posterior involvement in sarcoid-related uveitis. Am J Ophthalmol. 2013;155:1068-1074.e1 pubmed publisher

Klein R, Myers C, Meuer S, Gangnon R, Sivakumaran T, Iyengar S, et al. Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study. JAMA Ophthalmol. 2013;131:383-92 pubmed publisher

Brookes C, Kuisma E, Alexander F, Allen L, Tipton T, Ram S, et al. Development of a large scale human complement source for use in bacterial immunoassays. J Immunol Methods. 2013;391:39-49 pubmed publisher

Yuan D, Yang Q, Liu X, Yuan D, Yuan S, Xie P, et al. Complement factor H Val62Ile variant and risk of age-related macular degeneration: a meta-analysis. Mol Vis. 2013;19:374-83 pubmed

Banda N, Mehta G, Ferreira V, Cortes C, Pickering M, Pangburn M, et al. Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis. J Immunol. 2013;190:3560-9 pubmed publisher

Bresin E, Rurali E, Caprioli J, Sanchez Corral P, Fremeaux Bacchi V, Rodriguez de Cordoba S, et al. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype. J Am Soc Nephrol. 2013;24:475-86 pubmed publisher

Zhang D, Huang X, Wang D, Li Y, Yao Y. Genetic variants of complement genes ficolin-2, mannose-binding lectin and complement factor H are associated with leprosy in Han Chinese from Southwest China. Hum Genet. 2013;132:629-40 pubmed publisher

Seddon J, Reynolds R, Yu Y, Rosner B. Validation of a prediction algorithm for progression to advanced macular degeneration subtypes. JAMA Ophthalmol. 2013;131:448-55 pubmed publisher

Zipfel P, Lauer N. Defective complement action and control defines disease pathology for retinal and renal disorders and provides a basis for new therapeutic approaches. Adv Exp Med Biol. 2013;735:173-87 pubmed

Barata L, Miwa T, Sato S, Kim D, Mohammed I, Song W. Deletion of Crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack. J Immunol. 2013;190:2886-95 pubmed publisher

Sofat R, Mangione P, Gallimore J, Hakobyan S, Hughes T, Shah T, et al. Distribution and determinants of circulating complement factor H concentration determined by a high-throughput immunonephelometric assay. J Immunol Methods. 2013;390:63-73 pubmed publisher

Kenney M, Chwa M, Atilano S, Pavlis J, Falatoonzadeh P, Ramirez C, et al. Mitochondrial DNA variants mediate energy production and expression levels for CFH, C3 and EFEMP1 genes: implications for age-related macular degeneration. PLoS ONE. 2013;8:e54339 pubmed publisher

Clark S, Ridge L, Herbert A, Hakobyan S, Mulloy B, Lennon R, et al. Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions. J Immunol. 2013;190:2049-57 pubmed publisher

Le Quintrec M, Zuber J, Moulin B, Kamar N, Jablonski M, Lionet A, et al. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome. Am J Transplant. 2013;13:663-75 pubmed publisher

Park S, Shin Y, Kim C, Park H, Seong Y, Kim B, et al. Immune evasion of Enterococcus faecalis by an extracellular gelatinase that cleaves C3 and iC3b. J Immunol. 2008;181:6328-36 pubmed

Perez Caballero D, García Laorden I, Cortés G, Wessels M, de Cordoba S, Alberti S. Interaction between complement regulators and Streptococcus pyogenes: binding of C4b-binding protein and factor H/factor H-like protein 1 to M18 strains involves two different cell surface molecules. J Immunol. 2004;173:6899-904 pubmed